SOPHiA GENETICS (SOPH) Free Cash Flow (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Free Cash Flow data on file, last reported at -$7.8 million in Q4 2025.

• For the quarter ending Q4 2025, Free Cash Flow rose 25.45% year-over-year to -$7.8 million; the trailing twelve-month figure through Dec 2025 stood at -$35.1 million (up 19.7% YoY), and the FY2025 full-year result was -$35.1 million, up 19.7% from the prior year.
• Free Cash Flow climbed to -$7.8 million in Q4 2025, from -$8.6 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$7.8 million in Q4 2025 to a low of -$22.2 million in Q3 2022.
• A 5-year average of -$12.6 million and a median of -$11.4 million in 2023 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow sank 67.01% in 2022 and surged 45.85% in 2023, its largest moves.
• Tracing SOPH's Free Cash Flow over 5 years: stood at -$15.3 million in 2021, then jumped by 40.73% to -$9.0 million in 2022, then plunged by 37.3% to -$12.4 million in 2023, then grew by 15.77% to -$10.5 million in 2024, then grew by 25.45% to -$7.8 million in 2025.
• Business Quant data shows SOPH's Free Cash Flow at -$7.8 million in Q4 2025, -$8.6 million in Q3 2025, and -$9.4 million in Q2 2025.